Company / Debt per Share
West Pharmaceutical Services Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$2.80
FY2025
5-year range
$2.76 / $3.42
FY2021-FY2025
Trend
+1.8%
vs FY2024
Sector context
#75 of 98
Health Care
What the data says
West Pharmaceutical Services's debt per share of $2.80 is lower than 77% of companies in the Health Care sector (FY2025). Debt per Share returned to growth in FY2025 after 5 years of decline, reaching $2.80.
Based on SEC 10-K filings.
2.80 in FY2025 with a 5-year CAGR of -4.0%.
Remained stable around $2.80 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -0.1%
- 5-Year CAGR
- -4.0%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 98This company $2.80 Sector average $46.19
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 1.8% year-over-year.
- Ranks #75 out of 98 companies in the Health Care sector.
- Peak debt per share was recorded in FY2019.
- Lowest debt per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.80 | +1.8% |
| FY2024 | $2.76 | -1.2% |
| FY2023 | $2.79 | -0.9% |
| FY2022 | $2.82 | -17.7% |
| FY2021 | $3.42 | -0.7% |
| FY2020 | $3.44 | -0.8% |
| FY2019 | $3.47 | +30.9% |
| FY2018 | $2.65 | -1.5% |
| FY2017 | $2.69 | -14.8% |
| FY2016 | $3.16 | -24.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026